U. S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer, by blocking a protein that fuels tumor growth in the vast majority of cases.
Source: [NPR News](https://www.npr.org/2026/08/27/g-s1-140410/fda-approves-landmark-pancreatic-cancer-drug)